Imlifidase more effective than plasma exchange in removing donor-specific antibodies in kidney transplant rejection
For kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)—a procedure that removes antibodies ...
Oct 28, 2024
0
0